Public Profile

Virax Biolabs Group Limited

Virax Biolabs Group Limited, headquartered in Great Britain, is a pioneering entity in the biotechnology sector, specialising in innovative solutions for viral infections and immune health. Founded in 2020, the company has rapidly established itself as a key player in the development of diagnostic tools and therapeutic products aimed at enhancing global health outcomes. With a focus on cutting-edge research and development, Virax Biolabs offers unique products that address critical needs in the healthcare market, particularly in the realm of viral diagnostics. Their commitment to quality and innovation has positioned them favourably within the industry, earning recognition for their contributions to public health. As they continue to expand their operational footprint, Virax Biolabs remains dedicated to advancing the science of virology and improving patient care worldwide.

DitchCarbon Score

How does Virax Biolabs Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Virax Biolabs Group Limited's score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Let us know if this data was useful to you

Virax Biolabs Group Limited's reported carbon emissions

Virax Biolabs Group Limited, headquartered in Great Britain, currently does not have any publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of concrete data, it is essential to monitor the company's future disclosures for any developments in their climate commitments or sustainability initiatives.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Virax Biolabs Group Limited's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Virax Biolabs Group Limited is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Virax Biolabs Group Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Abbott

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Qiagen

DE
Other services (93)
Updated 3 days ago

Roche Holding AG

CH
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Adaptive Biotechnologies

US
Health and social work services (85)
Updated 16 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers